DVL1 and urinary bladder carcinoma: Moreover, ATF5 upregulation enhanced DVL1 promoter-driven luciferase activity (Fig. 4C) and DVL1 expression (Fig. 4D and E) in bladder cancer cells, while ATF5 knockdown exhibited the opposite effects (Fig. 4C–E).